Medical devices: the FDA/COFEPRIS custody opportunity

Short answer: sellable custody

The manufacturer is not buying “cheap truck”: they buy that every lot move has an auditable story. The T21 column includes medical devices among four nearshoring sectors (USD 35–50B, Pulsómetro Logístico 2026) — certainty there is custody, not spot rate.

Manufacturer / 3PL constraint

The device manufacturer is not buying “the cheapest truck”: they buy not reopening a sanitary audit when they switch operators. This matrix is for quality, operations, and freight buying: which risk each custody product prevents.

FDA and COFEPRIS on the corridor

FDA (medical devices, US) and COFEPRIS (Mexico counterpart) are not the same rulebook, but both require that you can show who handled the lot, when, and under what conditions.

In Mexico, NOM-241-SSA1-2025 (good manufacturing practice for medical devices) reinforces storage, distribution, and transport. When the manufacturer outsources the move, it usually requires a technical agreement defining responsibilities, temperature, and traceability — a generic freight clause is not enough.

Operating guides (e.g. MedEnvoy on COFEPRIS warehousing) stress temperature monitoring in transit, segregation of rejected product, and lot-level records. If the device is cold-sensitive, the temperature log must travel on the same ID as the lot — not a separate spreadsheet.

On the US side, unique device identification (UDI) and, for tracked devices (21 CFR 821), distribution records can be requested within business days. Your logistics layer is not an FDA ruling, but it is the movement evidence quality needs to respond.

Good distribution practice (GDP / BPD) — see GDP/BPD glossary — is the panel entry ticket. The sellable product is the lot-and-trip file. CTPAT (customs security) is a different layer: do not confuse a CTPAT logo with sanitary custody.

Evidence per lot and trip

Minimum layer that manufacturer quality and operations will ask of the carrier or 3PL. Use it when building the trip ID: avoid arriving at an audit with “the lot was on the truck” and no proof.

Operational chain of custody

Operating flow from lot assignment to closed delivery. Prevents gaps where “someone else” touched the product with no trail.

Generic freight vs documented custody

Comparison for freight buying and quality: same corridor, different product. If the customer is medical devices, do not compete on rate alone.

Carrier checklist

Closing list for the carrier or 3PL that wants to sell custody — not just a box — on medical devices. Use it before quoting or renewing a manufacturer panel: avoid promising GDP/BPD without per-trip evidence.

Regulatory file

When quality or COFEPRIS/FDA ask for the lot, the product is recovering it in hours — not rebuilding it from email. There the answer is one ID that links lot, trip, documents, and telemetry. OCL Cargo builds that file as an autonomous TMS: agents operate screens, audit before payment, and escalate exceptions. Your team only when something does not match; it coexists with your ERP or TMS.

It does not replace the manufacturer’s quality team or certify good distribution practice (GDP/BPD). A 6–8 week pilot shows whether the custody file opens from the ID when they ask. The sector frame follows the T21 column (11 Aug 2026).

What is your pain?

If your constraint is not chain of custody, route to the product that is taxing margin:

Related reading

• Border margin hub
• Automotive: origin file
• Electronics: guaranteed hour
• Processed foods: delivery reconciliation
• Documented custody (definition)
• GDP/BPD glossary
• Trip operating file

Sources

• Pulsómetro Logístico 2026 — ConaLog
• FDA — Medical Devices
• FDA — Unique Device Identification (UDI)
• MedEnvoy — COFEPRIS warehousing / distribution compliance
• COFEPRIS — Medical devices
• CBP — CTPAT (customs security, distinct from sanitary custody)
• Centro México Digital — México Inteligente

Frequently asked questions